Residual fish skin has formed the basis of one of Iceland’s fastest growing companies, Kerecis. Skin from cold water fish is naturally rich in Omega-3, which accelerates wound healing and is also ideal for human tissue as there is no risk of infection between such cold-water fish and humans. Kerecis’ Omega-3 consists of intact fish skin that is quickly covered by living tissue when transplanted onto a burn injury. This product could be useful in treating diabetes ulcers. The company’s vision is to become the world leader in tissue regeneration by sustainably harnessing nature’s own remedies
The Kerecis technology was invented by the company’s founder and CEO, Fertram Sigurjonsson. The initial Kerecis products have been approved by the FDA as well as by European regulatory authorities.